Objective:

The article discusses limitations of current sepsis diagnosis, the potential role of emerging biomarkers in risk stratification, and challenges in translating biomarker science into clinical workflows.

Approach:

• Current diagnosis: Clinicians rely on clinical observations and blood tests that typically identify inflammation. When infection is suspected, microbiological testing may be initiated; blood culture and organism identification can be accurate and guide antibiotic selection, but may take 48 hours or more.
• Biomarker under investigation: MicrosensDx is developing a diagnostic test based on the ratio of oxidized to total pentraxin 3 (PTX3). The interviewees describe published research associating higher ratios with more severe sepsis and a decline in the ratio as patients improve.

Key Findings:

• Sepsis symptoms are varied and nonspecific, and routine inflammation tests may not distinguish a dangerous trajectory from other causes of inflammation.
• The interviewees report that published research found higher oxidized-to-total PTX3 ratios associated with more severe sepsis, with ratios appearing to decline as patients improve.
• The interviewees describe serial PTX3 measurements as a possible way to assess sepsis risk and monitor disease course or response to treatment; MicrosensDx is developing a diagnostic test.

Interpretation:

The interview presents oxidized-to-total PTX3 as a candidate biomarker for risk stratification and monitoring, potentially used alongside clinical findings and microbiological testing.

Limitations:

• The article does not provide study design, sample size, or quantitative performance estimates for the cited PTX3 research.
• The source describes the PTX3 diagnostic test as under development.
• The interviewee says the specificity of CRP, lactate, and procalcitonin in early undifferentiated presentations remains debated.

Conclusion:

The interviewees describe a need for earlier, more specific sepsis assessment and present oxidized-to-total PTX3 as a biomarker under investigation for that purpose.

Sources:

• The Search for a Sepsis Signal